Literature DB >> 11444928

Differential regulation of myocardial NF kappa B following acute or chronic TNF-alpha exposure.

S B Haudek1, D D Bryant, B P Giroir.   

Abstract

Tumor necrosis factor alpha (TNF-alpha) is a critical mediator of myocardial dysfunction during acute inflammatory states. TNF-alpha is also present in the serum of patients with chronic cardiac diseases. In monocytes, TNF-alpha stimulates cells by activating distinct signaling pathways that involve nuclear translocation of NF kappa B. Since NF kappa B may also regulate the expression of genes that could contribute to myocardial dysfunction, the cardiomyocyte NF kappa B activation following acute or chronic TNF-alpha challenges was investigated. To accomplish this, the authors either acutely administered TNF-alpha to healthy mice, or used transgenic mice which chronically overexpress TNF-alpha exclusively in cardiac myocytes. Following acute administration of TNF-alpha, cardiac NF kappa B translocation was detected from 15 min to 2 h post-challenge. The time course of I kappa B alpha degradation was consistent with the kinetics of NF kappa B translocation. I kappa B beta degradation was slower and less dramatic. In transgenic mice chronically overexpressing TNF-alpha, myocardial NF kappa B activation was detected at all ages tested (21, 40, and 75 days). In contrast to acutely challenged animals, two distinct NF kappa B proteins were activated in chronically challenged animals, p50--65 heterodimers as well as p50 homodimers. Activation of both could be transiently blocked by administration of a recombinant chimeric TNF-alpha receptor antagonist (rhTNFR:Fc). I kappa B alpha, but not I kappa B beta, levels were elevated in transgenics when compared to wild-type animals. These data indicate that following acute TNF-alpha administration, which simulates bacterial sepsis, myocardial p50-p65 translocates within minutes. Chronic TNF-alpha exposure, which is thought to occur in long-standing congestive heart failure, results in translocation of transcriptionally inactive p50 homodimers in addition to transcriptionally active p50--65 heterodimers. It is speculated that activation of p50 homodimers constitutes an adaptive response to minimize the inflammatory consequences of chronic cardiac TNF-alpha exposure. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11444928     DOI: 10.1006/jmcc.2001.1388

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  8 in total

1.  JNK and NF-κB signaling pathways are involved in cytokine changes in patients with congenital heart disease prior to and after transcatheter closure.

Authors:  Shunyang Fan; Kefang Li; Deyin Zhang; Fuyun Liu
Journal:  Exp Ther Med       Date:  2017-12-05       Impact factor: 2.447

2.  Identification of a NF-κB cardioprotective gene program: NF-κB regulation of Hsp70.1 contributes to cardioprotection after permanent coronary occlusion.

Authors:  Michael E Wilhide; Michael Tranter; Xiaoping Ren; Jing Chen; Maureen A Sartor; Mario Medvedovic; W Keith Jones
Journal:  J Mol Cell Cardiol       Date:  2011-03-23       Impact factor: 5.000

3.  Do multiple nuclear factor kappa B activation mechanisms explain its varied effects in the heart?

Authors:  Rajesh Kumar; Qian Chen Yong; Candice M Thomas
Journal:  Ochsner J       Date:  2013

4.  FGF-16 is a target for adrenergic stimulation through NF-kappaB activation in postnatal cardiac cells and adult mouse heart.

Authors:  Alina G Sofronescu; Karen A Detillieux; Peter A Cattini
Journal:  Cardiovasc Res       Date:  2010-01-22       Impact factor: 10.787

5.  Differential hypoxic tolerance is mediated by activation of heat shock response and nitric oxide pathway.

Authors:  Kanika Jain; Geetha Suryakumar; Lilly Ganju; Shashi Bala Singh
Journal:  Cell Stress Chaperones       Date:  2014-03-04       Impact factor: 3.667

Review 6.  TNF Tolerance in Monocytes and Macrophages: Characteristics and Molecular Mechanisms.

Authors:  René Huber; Rolf Bikker; Bastian Welz; Martin Christmann; Korbinian Brand
Journal:  J Immunol Res       Date:  2017-11-08       Impact factor: 4.818

7.  Astaxanthin suppresses lipopolysaccharide‑induced myocardial injury by regulating MAPK and PI3K/AKT/mTOR/GSK3β signaling.

Authors:  Wen-Jie Xie; Guo Hou; Lu Wang; Sha-Sha Wang; Xiao-Xing Xiong
Journal:  Mol Med Rep       Date:  2020-08-19       Impact factor: 2.952

Review 8.  Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.

Authors:  Rosario Peluso; Giovanni Cafaro; Alessandro Di Minno; Salvatore Iervolino; Pasquale Ambrosino; Gelsy Lupoli; Matteo Nicola Dario Di Minno
Journal:  Clin Rheumatol       Date:  2013-04-16       Impact factor: 3.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.